FY26 Annual Report
Filed with ASX · · 42 pages · English
This Appendix 4E should be read in conjunction with the Company’s Annual Report for the year ended 30 June 2026. The FY2025 result included a $3,892,596 gain on extinguishment arising from the DOCA. Dividends There were no dividends paid, recommended or declared during the current financial period. Review of results The Company reported a net loss after tax of $428,603 compared with $1,463,310 in
Genetic Technologies Limited on 6ix
Story so far
Earlier from Genetic Technologies
- Quarterly Activities/Appendix 4C Cash Flow Report June 2026
- FY25 Appendix 4E & Annual Report
- Suspension from Official Quotation - Annual Listing Fees
- Quarterly Activities/Appendix 4C Cash Flow Report Sept 2025
- Quarterly Activities/Appendix 4C Cash Flow Report June 2025
Later from Genetic Technologies
All Genetic Technologies news releasesFollow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies